Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).
This study is currently recruiting participants.
Verified February 2013 by Swiss Group for Clinical Cancer Research
Study NCT01116219
Information provided by Swiss Group for Clinical Cancer Research
First Received on April 27, 2010.
Last Updated on February 4, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
